Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03220477
Brief Title: Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

First Submitted : July 14, 2017
First Submitted that Met QC Criteria : July 14, 2017
First Posted : July 18, 2017

Last Update Submitted that Met QC Criteria : November 5, 2019
Last Update Posted : November 6, 2019